Shawn Demehri, MD, PhD | MGH Research Scholar Profile
MGH Research Scholars Program
The MGH Research Scholars Program was established to support early career researchers with innovative yet unproven ideas that have the potential to transform the future of medicine. Funded 100% through philanthropy, this program gives researchers the freedom and flexibility they need to follow the science wherever it leads. History has shown that brilliant scientists who are given free rein to explore new frontiers make the greatest, often unexpected, advances.
Deploying the Patient’s Own Immune System to Prevent Cancer
My research aims to establish the foundation for the field of cancer immunoprevention, which can benefit many patients at high risk of cancer development and recurrence. Ultimately, my research aims to elucidate novel strategies to deploy patient’s immune system to eliminate early malignant cells and prevent cancer.
Our lab studies the critical elements that initiate a productive immune response against early stages of cancer development. We have discovered immune factors that potently suppress early cancer development in the skin, breast and other organs.
We have taken these fundamental discoveries to clinical trials and established that topical induction of immune factors effectively eliminates pre-cancerous skin lesions and prevents skin cancer. This topical immunotherapy is now being used by dermatologists around the world to prevent and treat skin cancer.
In parallel, my team has discovered commensal viruses—viruses that live in symbiosis with the human body—as novel targets attracting the immune cells to detect and eliminate pre-malignant cells within the normal tissues. This discovery has uncovered a previously unknown beneficial role for commensal viruses in promoting human health.
We have extended our research to understand the impact of aberrant immune activation—the ability of viruses to disrupt the body’s adaptive immune response by suppressing immunity or causing the growth of pathological legions—in promoting cancer development in the context of chronic inflammation in the skin, colon, pancreas and liver.
44 Mass General Investigators Named Highly Cited Researchers of 2022
According to Clarivate Analytics’ Highly Cited Researchers Report
Research at Mass General
Every day, our clinicians and scientists chart new terrain in biomedical research to treat and prevent human disease and advance patient care.